SG11201506446YA - Tert promoter mutations in gliomas and a subset of tumors - Google Patents

Tert promoter mutations in gliomas and a subset of tumors

Info

Publication number
SG11201506446YA
SG11201506446YA SG11201506446YA SG11201506446YA SG11201506446YA SG 11201506446Y A SG11201506446Y A SG 11201506446YA SG 11201506446Y A SG11201506446Y A SG 11201506446YA SG 11201506446Y A SG11201506446Y A SG 11201506446YA SG 11201506446Y A SG11201506446Y A SG 11201506446YA
Authority
SG
Singapore
Prior art keywords
gliomas
tumors
subset
tert promoter
promoter mutations
Prior art date
Application number
SG11201506446YA
Inventor
Yan Hai
Vogelstein Bert
Papadopoulos Nikolas
W Kinzler Kenneth
Jiao Yuchen
Bettegowda Chetan
D Bigner Darell
Original Assignee
Univ Duke
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51354619&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201506446Y(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Duke, Univ Johns Hopkins filed Critical Univ Duke
Publication of SG11201506446YA publication Critical patent/SG11201506446YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201506446YA 2013-02-18 2014-02-18 Tert promoter mutations in gliomas and a subset of tumors SG11201506446YA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361765909P 2013-02-18 2013-02-18
US201361766857P 2013-02-20 2013-02-20
US201361772249P 2013-03-04 2013-03-04
PCT/US2014/016906 WO2014127359A1 (en) 2013-02-18 2014-02-18 Tert promoter mutations in gliomas and a subset of tumors

Publications (1)

Publication Number Publication Date
SG11201506446YA true SG11201506446YA (en) 2015-09-29

Family

ID=51354619

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201506446YA SG11201506446YA (en) 2013-02-18 2014-02-18 Tert promoter mutations in gliomas and a subset of tumors

Country Status (7)

Country Link
US (1) US10711310B2 (en)
EP (2) EP2956556B1 (en)
JP (3) JP6574385B2 (en)
KR (1) KR101832948B1 (en)
CN (1) CN105683391A (en)
SG (1) SG11201506446YA (en)
WO (1) WO2014127359A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102089444A (en) 2008-05-14 2011-06-08 德玛泰克国际公司 Diagnosis of melanoma and solar lentigo by nucleic acid analysis
WO2014127359A1 (en) 2013-02-18 2014-08-21 Duke University Tert promoter mutations in gliomas and a subset of tumors
CN104805206B (en) * 2015-04-29 2017-06-20 苏州工业园区为真生物医药科技有限公司 The kit and its detection method of detection TERT gene promoter mutation
WO2017011440A1 (en) * 2015-07-14 2017-01-19 The Johns Hopkins University Detection of tumor-derived dna in cerebrospinal fluid
CN105695596A (en) * 2016-03-22 2016-06-22 南京艾迪康医学检验所有限公司 Method and primer as well as kit for detecting mutation sites of promoters C250T and C228T of TERT (Telomerase Reverse Transcriptase) gene
JP7072825B2 (en) * 2017-09-13 2022-05-23 三菱電機ソフトウエア株式会社 Copy number measuring device, copy number measuring program and copy number measuring method
CN107541557A (en) * 2017-09-27 2018-01-05 迈基诺（重庆）基因科技有限责任公司 A kind of fluorescence quantifying PCR method for detecting mankind's TERT gene promoter hot spot mutations and application thereof
AU2019222462A1 (en) * 2018-02-14 2020-09-03 Dermtech, Inc. Novel gene classifiers and uses thereof in non-melanoma skin cancers
JP2022524641A (en) 2019-03-26 2022-05-09 ダームテック，インク． New gene classifiers and their use in skin cancer
KR102203850B1 (en) * 2019-04-09 2021-01-18 사회복지법인 삼성생명공익재단 Composition for diagnosing or prognosising gliomas and a method for providing information for gliomas using same marker
KR20210026616A (en) * 2019-08-30 2021-03-10 지니너스 주식회사 PCR primer composition for detecting mutation of telomerase reverse transcriptase and uses thereof
KR20220068581A (en) * 2020-11-19 2022-05-26 (주)큐리진 Modified protein regulator of human Termerase reverse transcriptase for regulating cancer cell-specific gene expression and anti-tumor adenovirus comprising the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610839B1 (en) * 1997-08-14 2003-08-26 Geron Corporation Promoter for telomerase reverse transcriptase
ATE290213T1 (en) * 1997-10-21 2005-03-15 Cancer Rec Tech Ltd DETECTION OF CELL GROWTH ABNORMALITY
EP1394268A1 (en) * 2002-08-16 2004-03-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) HNF1alpha as a tumor suppressor gene, and diagnostic and therapeutic applications thereof
US20060088850A1 (en) * 2004-05-28 2006-04-27 Fred Hutchinson Cancer Research Center Method for genome-wide analysis of palindrome formation and uses thereof
WO2014127359A1 (en) 2013-02-18 2014-08-21 Duke University Tert promoter mutations in gliomas and a subset of tumors

Also Published As

Publication number Publication date
JP7191140B2 (en) 2022-12-16
EP2956556B1 (en) 2019-04-10
JP2016506760A (en) 2016-03-07
EP2956556A4 (en) 2016-10-12
KR20150132181A (en) 2015-11-25
EP2956556A1 (en) 2015-12-23
EP3360979A1 (en) 2018-08-15
JP2021078521A (en) 2021-05-27
CN105683391A (en) 2016-06-15
US20150361507A1 (en) 2015-12-17
EP3360979B1 (en) 2020-05-20
US10711310B2 (en) 2020-07-14
KR101832948B1 (en) 2018-02-28
WO2014127359A1 (en) 2014-08-21
JP6574385B2 (en) 2019-09-11
JP2018050621A (en) 2018-04-05

Similar Documents

Publication Publication Date Title
SG11201506446YA (en) Tert promoter mutations in gliomas and a subset of tumors
IL263026A (en) Ibrutinib combination therapy
HK1254296A1 (en) Therapeutic compounds and uses thereof
EP3412222C0 (en) Surgical stapler with partial pockets
GB201322725D0 (en) Cancer therapy
HK1221721A1 (en) Modified bet-protein-inhibiting dihydroquinoxalinones and dihydropyridopyrazinones bet
HK1217092A1 (en) Therapeutic compounds and uses thereof
EP2968345A4 (en) Dual mek/pi3k inhibitors and therapeutic methods using the same
HK1220900A1 (en) Cancer therapy
SG11201507847UA (en) Cancer therapy
ZA201507755B (en) Tumor-selective combination therapy
ZA201607581B (en) Dosage forms and therapeutic uses l-4lchlorokynurenine
GB2515865B (en) Use of galactooligosaccharides in therapy
EP2961412A4 (en) Cancer therapy
GB201310755D0 (en) Therapy
EP2978521A4 (en) Inclined baseplate in dehydrogenation reactor
IL241768B (en) 2β,3α,5α-trihydroxy-androst-6-one, preparation methods and uses thereof
IL238174A0 (en) Combination therapy with volasertib
GB201308753D0 (en) Compounds and their use in therapy
GB201518731D0 (en) Tumour Therapy
GB201309498D0 (en) Novel diagnosis and therapy
GB201308365D0 (en) Tumour therapy
GB201321504D0 (en) Novel analgesic therapy
GB201202945D0 (en) Novel cancer therapies and methods
GB201313895D0 (en) Novel analgesic therapy